Biodesix (BDSX) Other Accumulated Expenses (2019 - 2026)

Biodesix (BDSX) has reported Other Accumulated Expenses for 8 consecutive years, with $927000.0 the latest figure, recorded in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $927000.0, down 57.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $927000.0 (down 57.69% YoY), and the FY2025 annual result was $992000.0, down 58.23% from the prior year.
• Other Accumulated Expenses was $927000.0 for Q1 2026 at Biodesix, down from $992000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $3.5 million in Q1 2024 and troughed at $37000.0 in Q1 2022.
• Average Other Accumulated Expenses over 5 years is $1.7 million, with a median of $2.1 million recorded in 2022.
• Year-over-year, Other Accumulated Expenses tumbled 99.2% in 2022 and jumped 2301.39% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $2.3 million in 2022, then grew by 24.06% to $2.9 million in 2023, then fell by 17.31% to $2.4 million in 2024, then sank by 58.23% to $992000.0 in 2025, then declined by 6.55% to $927000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $927000.0 in Q1 2026, $992000.0 in Q4 2025, and $2.0 million in Q3 2025.